These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35563420)
1. Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Di Bonaventura G; Lupetti V; De Fabritiis S; Piccirilli A; Porreca A; Di Nicola M; Pompilio A Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563420 [TBL] [Abstract][Full Text] [Related]
2. Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis. Di Bonaventura G; Lupetti V; Di Giulio A; Muzzi M; Piccirilli A; Cariani L; Pompilio A Microbiol Spectr; 2023 Aug; 11(4):e0035223. PubMed ID: 37306577 [TBL] [Abstract][Full Text] [Related]
3. Repurposing the Veterinary Antibiotic Apramycin for Antibacterial and Antibiofilm Activity Against Di Bonaventura G; Lupetti V; Verginelli F; Giancristofaro S; Barbieri R; Gherardi G; Pompilio A Front Microbiol; 2021; 12():801152. PubMed ID: 35185826 [TBL] [Abstract][Full Text] [Related]
4. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms. Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746 [No Abstract] [Full Text] [Related]
5. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa. Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. McCaughey G; McKevitt M; Elborn JS; Tunney MM J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067 [TBL] [Abstract][Full Text] [Related]
8. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms. Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354 [TBL] [Abstract][Full Text] [Related]
10. Triclosan Is an Aminoglycoside Adjuvant for Eradication of Pseudomonas aeruginosa Biofilms. Maiden MM; Hunt AMA; Zachos MP; Gibson JA; Hurwitz ME; Mulks MH; Waters CM Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29661867 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice. Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865 [No Abstract] [Full Text] [Related]
12. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates. Jabalameli F; Emaneini M; Beigverdi R; Halimi S; Siroosi M Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):61. PubMed ID: 37475017 [TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells. Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834 [TBL] [Abstract][Full Text] [Related]
14. The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential. Maiden MM; Zachos MP; Waters CM J Antimicrob Chemother; 2019 Apr; 74(4):894-906. PubMed ID: 30624737 [TBL] [Abstract][Full Text] [Related]
15. Activity of Antibiotics against Pseudomonas aeruginosa in an Diaz Iglesias Y; Van Bambeke F Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015047 [No Abstract] [Full Text] [Related]
16. Effect of L-arginine on cystic fibrosis Eisha S; Morris AJ; Martin I; Yau YCW; Grasemann H; Waters V Antimicrob Agents Chemother; 2024 Aug; 68(8):e0033624. PubMed ID: 39023260 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial effects of Melaleuca alternifolia (tea tree) essential oil against biofilm-forming multidrug-resistant cystic fibrosis-associated Pseudomonas aeruginosa as a single agent and in combination with commonly nebulized antibiotics. Haines RR; Putsathit P; Tai AS; Hammer KA Lett Appl Microbiol; 2022 Sep; 75(3):578-587. PubMed ID: 34687564 [TBL] [Abstract][Full Text] [Related]
18. [Effects of Imipenem, Tobramycin and Curcumin on Biofilm Formation of Pseudomonas aeruginosa Strains]. Karaman M; Fırıncı F; Arıkan Ayyıldız Z; Bahar IH Mikrobiyol Bul; 2013 Jan; 47(1):192-4. PubMed ID: 23390919 [TBL] [Abstract][Full Text] [Related]
19. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro. Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003 [TBL] [Abstract][Full Text] [Related]
20. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms. Field TR; White A; Elborn JS; Tunney MM Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]